Saturday 17 October 2026
Export CERS’s income statement to Excel — free account
Cerus Corporation
CERS Healthcare Medical Devices
In the quarter to June 2026, revenue grew 5.28%, EPS grew 50.3%, free cash flow fell 20.9% and total debt fell 23.5%, each against the same quarter a year earlier.
2.20
0.06
−2.65%
Follow CERS
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Piotroski F-Score |
5 | 5 | 4 | 4 | 3 | 5 | 3 | 5 | 4 | 4 |
P/S ratio |
1.68 | 1.41 | 2.08 | 3.51 | 7.31 | 9.93 | 6.29 | 8.78 | 7.51 | 11.23 |
Altman Z-Score |
(4.00) | (4.94) | (4.87) | (3.24) | (0.54) | 0.35 | (4.12) | (1.55) | (7.17) | (3.92) |
P/FCF ratio |
354.35 | 33.35 | 0.00 | 52.87 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Altman Z″-Score (non-manufacturers) |
(13.54) | (14.46) | (15.30) | (14.03) | (11.03) | (10.58) | (15.80) | (12.89) | (22.72) | (19.22) |
Beneish M-Score |
(2.87) | (3.35) | (2.22) | (2.52) | (2.51) | (2.66) | (1.34) | (3.05) | (2.44) | (2.82) |
P/Operating CF |
63.33 | 57.66 | (25.65) | (376.01) | (954.51) | (127.46) | (71.77) | (94.08) | (38.39) | (45.40) |
P/B ratio |
6.04 | 5.00 | 7.29 | 9.63 | 13.62 | 10.93 | 10.34 | 7.90 | 9.89 | 7.63 |
Price to Tangible BV |
6.17 | 5.11 | 7.47 | 9.82 | 13.84 | 11.07 | 10.61 | 8.06 | 10.39 | 7.91 |
EV/Sales |
1.68 | 1.43 | 2.16 | 3.33 | 6.94 | 9.18 | 5.85 | 7.62 | 7.01 | 9.90 |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
81.38 | 25.35 | (9.34) | (24.51) | (32.62) | (25.09) | (8.38) | (18.56) | (6.89) | (7.26) |
EV/FCF |
355.26 | 33.79 | (8.44) | 50.28 | (31.77) | (24.16) | (7.37) | (17.90) | (6.84) | (7.18) |
Quick Ratio |
1.12 | 1.73 | 1.50 | 1.17 | 1.97 | 2.58 | 2.04 | 2.40 | 3.16 | 2.92 |
Current Ratio |
1.73 | 2.39 | 2.14 | 1.45 | 2.38 | 3.06 | 2.55 | 2.79 | 3.89 | 3.50 |
Net Debt/EBITDA |
(0.14) | (0.30) | (0.51) | 1.04 | 1.31 | 1.55 | 0.65 | 1.64 | 0.55 | 0.88 |
Debt/Assets |
37.81% | 41.89% | 40.35% | 32.01% | 29.23% | 21.73% | 26.84% | 18.27% | 30.33% | 18.72% |
Debt/Equity |
1.29 | 1.48 | 1.49 | 1.02 | 0.81 | 0.46 | 0.78 | 0.35 | 0.77 | 0.34 |
Asset Turnover |
1.11 | 1.01 | 0.90 | 0.83 | 0.70 | 0.59 | 0.57 | 0.58 | 0.51 | 0.32 |
Operating CF/Net income |
(0.31) | (0.54) | 1.15 | 0.60 | 0.62 | 0.70 | 0.92 | 0.54 | 0.86 | 0.85 |
Capex/Depreciation |
(2.61) | (1.53) | (1.77) | 12.77 | (0.29) | (0.52) | (3.72) | (0.79) | (0.19) | (0.31) |
Interest Coverage |
(1.04) | (1.60) | (3.58) | (5.84) | (9.94) | (15.57) | (10.92) | (13.72) | (19.04) | (25.13) |
| (25.65%) | (37.92%) | (61.45%) | (55.49%) | (57.41%) | (74.42%) | (100.65%) | (93.25%) | (125.27%) | (82.47%) | |
| (7.39%) | (10.49%) | (18.03%) | (18.78%) | (23.70%) | (30.94%) | (43.31%) | (43.99%) | (60.07%) | (51.80%) | |
ROIC |
(8.22%) | (14.67%) | (27.87%) | (58.82%) | (119.11%) | (199.05%) | (262.55%) | 0.00% | (447.11%) | (693.97%) |
Return on Tangible Assets |
(18.88%) | (21.89%) | (43.82%) | (66.78%) | (45.03%) | (43.59%) | (76.88%) | (56.24%) | (87.95%) | (89.61%) |
Average Days of Receivables |
47.42 | 53.99 | 69.37 | 66.73 | 57.50 | 67.62 | 65.71 | 42.00 | 88.29 | 63.83 |
Research and Development Expense of Revenue |
28.97% | 29.26% | 36.21% | 34.04% | 39.93% | 56.38% | 64.38% | 55.97% | 65.68% | 79.75% |
Selling, General and Administrative Expense of Revenue |
34.61% | 37.70% | 40.43% | 44.25% | 50.96% | 58.66% | 70.60% | 74.74% | 102.51% | 124.65% |
Intangible Assets out of Total Assets |
0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 | 0.02 |
Share Based Compensation of Revenue |
9.78% | 11.36% | 10.85% | 12.99% | 14.78% | 15.78% | 14.20% | 13.67% | 18.23% | 20.53% |
Graham Net Nets |
0.04 | 0.03 | 0.00 | 0.03 | 0.03 | 0.06 | 0.03 | 0.10 | 0.08 | 0.11 |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
(3.89%) | (7.08%) | (9.58%) | (6.68%) | (4.55%) | (5.20%) | (12.32%) | (8.68%) | (15.73%) | (14.32%) |
Free Cash Flow Yield |
0.28% | 3.00% | (12.27%) | 1.89% | (2.99%) | (3.83%) | (12.61%) | (4.85%) | (13.65%) | (12.27%) |
Revenue per Share |
1.23 | 1.09 | 1.04 | 1.07 | 0.93 | 0.70 | 0.67 | 0.58 | 0.47 | 0.39 |
Operating CF per Share |
0.03 | 0.06 | (0.24) | (0.15) | (0.20) | (0.25) | (0.47) | (0.24) | (0.48) | (0.53) |
Capex per Share |
(0.02) | (0.02) | (0.03) | 0.22 | (0.01) | (0.01) | (0.06) | (0.01) | 0.00 | (0.01) |
Free Cash Flow per Share |
0.01 | 0.05 | (0.26) | 0.07 | (0.20) | (0.26) | (0.53) | (0.25) | (0.49) | (0.53) |
Cash per Share |
0.43 | 0.44 | 0.37 | 0.58 | 0.76 | 0.81 | 0.61 | 0.89 | 0.56 | 0.70 |
Shareholders Equity per Share |
0.34 | 0.31 | 0.30 | 0.39 | 0.50 | 0.63 | 0.41 | 0.64 | 0.36 | 0.57 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
0.34 | 0.31 | 0.30 | 0.39 | 0.50 | 0.63 | 0.41 | 0.64 | 0.36 | 0.57 |
Free Cash Flow |
1.11 | 8.52 | (47.76) | 12.49 | (34.83) | (43.43) | (74.43) | (32.39) | (52.59) | (54.09) |
Working Capital |
73.58 | 88.41 | 76.92 | 53.09 | 108.55 | 123.46 | 77.77 | 94.22 | 66.77 | 67.22 |
Capital Expenditures |
(3.73) | (2.84) | (4.60) | 38.10 | (0.91) | (1.61) | (8.93) | (1.14) | (0.35) | (0.56) |
Net Current Asset Value |
17.49 | 8.00 | 0.14 | 20.61 | 35.22 | 65.82 | 19.63 | 67.96 | 30.59 | 48.42 |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
0.02 | 0.01 | 0.02 | (0.20) | 0.01 | 0.01 | 0.10 | 0.02 | 0.01 | 0.01 |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.15 | 0.26 | 0.30 | 0.27 | 0.26 | 0.22 | 0.16 | 0.18 | 0.85 | 0.61 |
Cash ROIC |
0.48% | 3.85% | (23.99%) | 5.19% | (12.25%) | (15.21%) | (39.76%) | (13.96%) | (40.63%) | (36.35%) |
Accounts Receivable Turnover |
7.77 | 6.17 | 5.34 | 6.32 | 6.89 | 6.01 | 7.32 | 7.19 | 5.32 | 6.20 |
Accounts Payable Turnover |
3.78 | 3.55 | 2.46 | 2.18 | 2.12 | 1.77 | 1.64 | 2.14 | 2.30 | 2.94 |
Inventory Turnover |
1.99 | 2.07 | 2.03 | 2.69 | 2.54 | 1.93 | 2.02 | 2.26 | 1.67 | 1.74 |
Average Days of Payables |
108.93 | 98.07 | 124.38 | 160.71 | 204.76 | 214.73 | 242.30 | 214.55 | 177.78 | 154.43 |
Days of Inventory on Hand |
218.20 | 172.45 | 207.98 | 141.23 | 154.07 | 206.23 | 212.87 | 156.22 | 234.20 | 225.37 |
Average Receivables |
30.08 | 32.64 | 34.96 | 29.78 | 23.15 | 19.02 | 12.82 | 10.58 | 9.64 | 6.33 |
Average Payables |
24.85 | 22.77 | 28.42 | 34.31 | 29.91 | 23.20 | 20.39 | 14.78 | 9.78 | 6.90 |
Average Inventory |
47.13 | 39.01 | 34.44 | 27.90 | 25.02 | 21.37 | 16.51 | 14.00 | 13.49 | 11.67 |
Average Assets |
211.39 | 199.33 | 207.92 | 227.80 | 229.46 | 193.48 | 164.50 | 130.85 | 100.86 | 121.44 |
Average Common Equity |
60.93 | 55.17 | 61.00 | 77.09 | 94.71 | 80.43 | 70.79 | 61.73 | 48.36 | 76.28 |
Columns are period end dates